Related Experiment Video
Updated: Aug 10, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Prevention and management of strokes in patients with sickle cell disease
Miguel R Abboud1, George F Atweh
1Children's Cancer Center of Lebanon, American University of Beirut Medical Center, P.O. Box 11-0236 Riad El-Solh, Beirut 1107-2020, Lebanon. abboudm@aub.edu.lb
Insights
Children with sickle cell disease face high stroke risks. Transfusions can prevent strokes, but better risk stratification and alternative treatments are needed for effective stroke prevention.
Area of Science:
- Pediatric Neurology
- Hematology
- Medical Imaging
Background:
- Sickle cell disease (SCD) significantly increases stroke risk in children, with overt strokes affecting approximately 11% and silent infarcts being even more common.
- Current management primarily relies on chronic transfusions to prevent recurrent strokes, a strategy with limitations.
Purpose of the Study:
- To review current stroke prevention strategies in pediatric sickle cell disease.
- To highlight the need for improved stroke risk stratification beyond current methods.
- To explore alternative and adjunctive therapies to chronic transfusions.
Main Methods:
- Review of the Stroke Prevention Trial in Sickle Cell Anemia (STOP) findings.
- Discussion of transcranial Doppler (TCD) ultrasonography utility in identifying at-risk children.
- Exploration of emerging imaging, genetic, and neuropsychological assessment tools for risk stratification.
Main Results:
- Transcranial Doppler (TCD) ultrasonography effectively identifies children at high risk for stroke, with chronic transfusions reducing first stroke risk by 90% in these patients.
- A significant proportion (up to 60%) of children with abnormal TCD findings may not develop a stroke, indicating limitations in current risk prediction.
- Chronic transfusion regimens, while effective, present challenges and are not universally applicable.
Conclusions:
- More precise stroke risk stratification in pediatric sickle cell disease is crucial, utilizing advanced imaging, genetic, and neuropsychological assessments.
- Development of alternatives to chronic transfusions, such as hydroxyurea and other pharmacologic agents, is essential for improving outcomes in high-risk patients.
Abstract:
Overt strokes occur in about 11% of children with sickle cell disease, and many more develop silent infarcts. Until recently, the only available management intervention was the use of chronic transfusions to prevent stroke recurrence. The stroke prevention trial in sickle cell anemia (STOP) demonstrated that children at risk for strokes can be identified by transcranial Doppler (TCD) ultrasonography. In high-risk patients, the risk of first stroke can be decreased by 90% if patients are placed on chronic transfusion regimens. However, transfusing all patients with abnormal TCD is also problematic; as many as 60% do not seem to develop a stroke. At this time, a more precise stratification of stroke risk based on imaging studies, genetic studies, and neuropsychological testing is needed. Moreover, the development of alternatives to chronic transfusions, such as hydroxyurea and other pharmacologic therapies, may also improve the outlook for patients at high risk for stroke.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management